NASDAQ : BMRA
Biomerica, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.74 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 8.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Biomerica, Inc. (BMRA) reported revenue of 4.34M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year June - May; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 4.34M | 4.45M | 5.31M | 5.42M | 5.34M | 18.87M |
| Cost of Revenue | 4.30M | 4.09M | 4.81M | 4.80M | 4.89M | 15.89M |
| Gross Profit | 41.00K | 362.00K | 498.00K | 611.00K | 446.00K | 2.98M |
| Selling, General & Admin | 4.69M | 4.89M | 4.61M | 5.49M | 6.08M | 5.70M |
| Research & Development | 782.00K | 788.00K | 1.02M | 1.49M | 1.58M | 1.81M |
| Operating Expenses | 5.47M | 5.68M | 5.63M | 6.98M | 7.67M | 7.51M |
| Operating Income | -5.43M | -5.32M | -5.14M | -6.37M | -7.22M | -4.53M |
| Interest & Investment Income | 111.00K | 133.00K | 165.00K | 431.00K | 133.00K | 27.00K |
| Other Non Operating Income (Expenses) | 1.00K | |||||
| EBT Excluding Unusual Items | -5.32M | -5.19M | -4.97M | -5.94M | -7.09M | -4.51M |
| Gain (Loss) on Sale of Investments | 335.00K | 335.00K | ||||
| Other Unusual Items | 1.10M | |||||
| Pretax Income | -4.98M | -3.75M | -4.97M | -5.94M | -7.09M | -4.51M |
| Income Tax Expense | 26.00K | 23.00K | 1.00K | 42.00K | 51.00K | 24.00K |
| Net Income | -5.01M | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M |
| Net Income to Common | -5.01M | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M |
| Shares Outstanding (Basic) | 3.08M | 2.91M | 2.30M | 2.10M | 1.77M | 1.58M |
| Shares Outstanding (Diluted) | 3.08M | 2.91M | 2.30M | 2.10M | 1.77M | 1.58M |
| EPS (Basic) | -1.63 | -1.30 | -2.16 | -2.84 | -4.04 | -2.86 |
| EPS (Diluted) | -1.63 | -1.30 | -2.16 | -2.84 | -4.04 | -2.88 |
| Free Cash Flow | -3.96M | -3.42M | -3.84M | -5.41M | -5.54M | -536.00K |
| Free Cash Flow Per Share | -1.28 | -1.17 | -1.67 | -2.57 | -3.13 | -0.34 |
| Gross Margin | 0.95% | 8.13% | 9.38% | 11.28% | 8.35% | 15.78% |
| Operating Margin | -125.15% | -119.47% | -96.72% | -117.58% | -135.29% | -24.03% |
| Profit Margin | -115.47% | -84.77% | -93.64% | -110.40% | -133.73% | -24.01% |
| Free Cash Flow Margin | -91.17% | -76.83% | -72.34% | -99.94% | -103.73% | -2.84% |
| EBITDA | -5.36M | -5.24M | -5.05M | -6.29M | -7.14M | -4.20M |
| EBITDA Margin | -123.49% | -117.74% | -95.09% | -116.08% | -133.71% | -22.23% |
| D&A For EBITDA | 72.00K | 77.00K | 87.00K | 81.00K | 84.00K | 339.00K |
| EBIT | -5.43M | -5.32M | -5.14M | -6.37M | -7.22M | -4.53M |
| EBIT Margin | -125.15% | -119.47% | -96.72% | -117.58% | -135.29% | -24.03% |
| Advertising Expenses | 35.00K | 35.00K | 101.00K | 156.00K | 76.00K |
Balance sheet
Fiscal year June - May; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.73M | 1.31M | 2.40M | 4.17M | 9.72M | 5.92M |
| Cash & Short-Term Investments | 2.73M | 1.31M | 2.40M | 4.17M | 9.72M | 5.92M |
| Receivables | 897.00K | 785.00K | 731.00K | 947.00K | 722.00K | 774.00K |
| Inventory | 1.63M | 1.71M | 1.49M | 2.38M | 2.06M | 2.42M |
| Prepaid Expenses | 145.00K | 216.00K | 255.00K | 238.00K | 300.00K | 320.00K |
| Total Current Assets | 5.41M | 4.02M | 4.88M | 7.73M | 12.80M | 9.43M |
| Property, Plant & Equipment | 1.88M | 1.95M | 564.00K | 943.00K | 1.25M | 1.52M |
| Long-Term Investments | 500.00K | 500.00K | 165.00K | 165.00K | 165.00K | 165.00K |
| Other Intangible Assets | 204.00K | 209.00K | 228.00K | 212.00K | 165.00K | 170.00K |
| Other Long-Term Assets | 81.00K | 83.00K | 113.00K | 203.00K | 79.00K | 96.00K |
| Total Assets | 8.07M | 6.76M | 5.95M | 9.25M | 14.45M | 11.37M |
| Accounts Payable | 1.50M | 377.00K | 295.00K | 560.00K | 344.00K | 736.00K |
| Accrued Expenses | 552.00K | 1.29M | 1.03M | 1.23M | 1.24M | 883.00K |
| Short-Term Debt | 500.00K | 500.00K | ||||
| Current Portion of Leases | 240.00K | 235.00K | 358.00K | 326.00K | 297.00K | 341.00K |
| Other Current Liabilities | 47.00K | 83.00K | 55.00K | 85.00K | 60.00K | 51.00K |
| Total Current Liabilities | 2.84M | 2.48M | 1.74M | 2.20M | 1.95M | 2.01M |
| Long-Term Leases | 1.59M | 1.65M | 100.00K | 459.00K | 785.00K | 1.04M |
| Total Liabilities | 4.42M | 4.13M | 1.84M | 2.66M | 2.73M | 3.05M |
| Common Stock | 368.00K | 255.00K | 203.00K | 168.00K | 1.35M | 1.03M |
| Additional Paid-In Capital | 61.57M | 59.43M | 57.17M | 54.72M | 52.70M | 42.45M |
| Retained Earnings | -58.17M | -56.94M | -53.17M | -48.20M | -42.22M | -35.08M |
| Comprehensive Income & Other | -112.00K | -108.00K | -105.00K | -102.00K | -110.00K | -74.00K |
| Total Common Equity | 3.65M | 2.63M | 4.11M | 6.59M | 11.72M | 8.32M |
| Shareholders' Equity | 3.65M | 2.63M | 4.11M | 6.59M | 11.72M | 8.32M |
| Total Liabilities & Equity | 8.07M | 6.76M | 5.95M | 9.25M | 14.45M | 11.37M |
| Total Debt | 2.33M | 2.38M | 458.00K | 785.00K | 1.08M | 1.38M |
| Net Cash (Debt) | 407.00K | -1.07M | 1.94M | 3.38M | 8.64M | 4.54M |
| Net Cash Per Share | 0.13 | -0.37 | 0.84 | 1.61 | 4.88 | 2.86 |
| Filing Date Shares Outstanding | 4.60M | 4.59M | 2.82M | 2.10M | 2.10M | 1.67M |
| Total Common Shares Outstanding | 4.60M | 3.20M | 2.55M | 2.10M | 2.10M | 1.61M |
| Working Capital | 2.57M | 1.53M | 3.13M | 5.53M | 10.85M | 7.42M |
| Book Value Per Share | 0.79 | 0.82 | 1.61 | 3.13 | 5.58 | 5.18 |
| Tangible Book Value | 3.44M | 2.42M | 3.88M | 6.38M | 11.56M | 8.15M |
| Tangible Book Value Per Share | 0.75 | 0.76 | 1.52 | 3.03 | 5.50 | 5.07 |
| Machinery | 1.58M | 1.59M | 1.59M | 1.54M | 1.52M | |
| Order Backlog | 604.00K | 1.32M | 755.00K | 655.00K | 754.00K |
Cash flow statement
Fiscal year June - May; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -5.01M | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M |
| Depreciation & Amortization | 398.00K | 421.00K | 400.00K | 374.00K | 351.00K | 595.00K |
| Loss (Gain) From Sale of Assets | 53.00K | |||||
| Loss (Gain) From Sale of Investments | -335.00K | -335.00K | ||||
| Stock-Based Compensation | 477.00K | 476.00K | 460.00K | 837.00K | 1.19M | 1.26M |
| Provision & Write-off of Bad Debts | -23.00K | 12.00K | 8.00K | -10.00K | 342.00K | -684.00K |
| Other Operating Activities | -108.00K | -77.00K | 4.00K | -205.00K | -174.00K | -772.00K |
| Change in Accounts Receivable | 331.00K | -66.00K | 209.00K | -215.00K | -291.00K | 1.36M |
| Change in Inventory | -53.00K | -140.00K | 882.00K | -115.00K | 534.00K | 1.56M |
| Change in Accounts Payable | 705.00K | 499.00K | -467.00K | 246.00K | -80.00K | 389.00K |
| Change in Other Net Operating Assets | -338.00K | -436.00K | -365.00K | -295.00K | -201.00K | 284.00K |
| Operating Cash Flow | -3.96M | -3.42M | -3.84M | -5.36M | -5.47M | -479.00K |
| Capital Expenditures | -51.00K | -64.00K | -57.00K | |||
| Sale (Purchase) of Intangibles | -1.00K | -1.00K | -37.00K | -64.00K | -14.00K | -113.00K |
| Investing Cash Flow | -1.00K | -1.00K | -37.00K | -115.00K | -78.00K | -170.00K |
| Short-Term Debt Issued | 500.00K | |||||
| Total Debt Issued | 500.00K | 500.00K | ||||
| Net Debt Issued (Repaid) | 500.00K | 500.00K | ||||
| Issuance of Common Stock | 3.17M | 1.87M | 2.16M | 10.10M | 2.48M | |
| Other Financing Activities | -21.00K | -40.00K | -47.00K | -81.00K | -705.00K | -85.00K |
| Financing Cash Flow | 3.65M | 2.33M | 2.11M | -81.00K | 9.39M | 2.39M |
| Foreign Exchange Rate Adjustments | -9.00K | -3.00K | -3.00K | 8.00K | -36.00K | -26.00K |
| Net Cash Flow | -320.00K | -1.09M | -1.77M | -5.55M | 3.80M | 1.72M |
| Free Cash Flow | -3.96M | -3.42M | -3.84M | -5.41M | -5.54M | -536.00K |
| Free Cash Flow Margin | -91.17% | -76.83% | -72.34% | -99.94% | -103.73% | -2.84% |
| Free Cash Flow Per Share | -1.28 | -1.17 | -1.67 | -2.57 | -3.13 | -0.34 |
| Levered Free Cash Flow | -1.58M | -2.30M | -1.80M | -3.14M | -2.65M | 1.07M |
| Unlevered Free Cash Flow | -1.58M | -2.30M | -1.80M | -3.14M | -2.65M | 1.07M |
| Cash Income Tax Paid | 25.00K | 22.00K | 10.00K | 41.00K | 51.00K | 24.00K |
| Change in Working Capital | 645.00K | -143.00K | 259.00K | -379.00K | -38.00K | 3.60M |
Ratios
Fiscal year June - May; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.91M | 7.38M | 7.76M | 9.77M | 23.05M | 44.98M |
| Enterprise Value | 7.50M | 6.24M | 5.25M | 5.31M | 20.88M | 36.25M |
| Last Close Price | 1.72 | 2.39 | 3.05 | 4.64 | 10.96 | 28.00 |
| Forward PE | 55.62 | 55.62 | 55.62 | 55.62 | 55.62 | |
| PS Ratio | 1.82 | 1.66 | 1.46 | 1.80 | 4.32 | 2.38 |
| PB Ratio | 2.17 | 2.81 | 1.89 | 1.48 | 1.97 | 5.40 |
| P/TBV Ratio | 2.30 | 3.05 | 2.00 | 1.53 | 1.99 | 5.52 |
| PEG Ratio | 4.32 | 4.32 | 4.32 | 4.32 | 4.32 | |
| EV/Sales Ratio | 1.73 | 1.40 | 0.99 | 0.98 | 3.91 | 1.92 |
| Debt / Equity Ratio | 0.64 | 0.91 | 0.11 | 0.12 | 0.09 | 0.17 |
| Net Debt / Equity Ratio | -0.11 | 0.41 | -0.47 | -0.51 | -0.74 | -0.55 |
| Net Debt / EBITDA Ratio | 0.08 | -0.20 | 0.38 | 0.54 | 1.21 | 1.08 |
| Net Debt / FCF Ratio | 0.10 | -0.31 | 0.51 | 0.62 | 1.56 | 8.47 |
| Asset Turnover | 0.58 | 0.70 | 0.70 | 0.46 | 0.41 | 1.63 |
| Inventory Turnover | 2.77 | 2.56 | 2.49 | 2.17 | 2.19 | 5.65 |
| Quick Ratio | 1.28 | 0.84 | 1.80 | 2.32 | 5.37 | 3.33 |
| Current Ratio | 1.91 | 1.62 | 2.80 | 3.51 | 6.58 | 4.69 |
| Return on Equity (ROE) | -113.80% | -112.10% | -92.99% | -65.28% | -71.23% | -51.63% |
| Return on Assets (ROA) | -45.47% | -52.35% | -42.25% | -33.57% | -34.96% | -24.44% |
| Return on Capital Employed (ROCE) | -103.70% | -124.40% | -122.20% | -90.30% | -57.70% | -48.40% |
| Earnings Yield | -94.61% | -51.16% | -64.05% | -61.21% | -30.98% | -10.07% |
| FCF Yield | -50.00% | -46.36% | -49.48% | -55.41% | -24.03% | -1.19% |
| Buyback Yield / Dilution | -26.67% | -26.90% | -9.22% | -18.87% | -11.69% | -6.24% |